CHILDRENS HOSP & RES CNTR OAKLAND
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $8.5M
- Transactions
- 593
- Companies
- 40
- Average per transaction
- $14,388
Who reported the payments
| Biomarin Pharmaceutical Inc. | $2,391,260 |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,069,726 |
| Bioverativ Therapeutics Inc. | $757,351 |
| Swedish Orphan Biovitrum AB | $646,046 |
| La Jolla Pharmaceutical Company | $488,610 |
| Shire North American Group Inc | $456,252 |
| AbbVie | $384,147 |
| Sanofi US Services Inc. | $321,718 |
| Jazz Pharmaceuticals Inc. | $321,364 |
| Genetix Biotherapeutics Inc | $254,775 |
| Bristol Myers Squibb | $227,146 |
| Cerus Corporation | $173,610 |
| New York Blood Center, Inc. | $144,300 |
| Novartis | $136,504 |
| GW Research Limited | $128,891 |
| Pfizer | $118,852 |
| Ultragenyx Pharmaceutical Inc. | $113,062 |
| Global Blood Therapeutics, Inc. | $108,864 |
| Agios Pharmaceuticals, Inc. | $42,403 |
| Terumo BCT, Inc. | $37,876 |
| PTC Therapeutics, Inc. | $30,008 |
| Med-el Corporation | $25,410 |
| Janssen Research & Development, LLC | $24,270 |
| Genentech, Inc. | $15,795 |
| Lucira Health, Inc. | $14,879 |
| Bio-rad Laboratories, Inc. | $10,450 |
| Integra Lifesciences Corporation | $9,075 |
| Vitalant | $8,470 |
| Sobi, Inc | $6,000 |
| National Marrow Donor Program | $5,975 |
| Thermo Fisher Scientific Asheville LLC | $5,591 |
| Catalent Pharma Solutions, LLC | $5,000 |
| E.r. Squibb & Sons, L.L.C. | $4,500 |
| Novo Nordisk | $4,000 |
| Abbott | $4,000 |
| Stryker | $3,946 |
| Sanofi | $3,700 |
| Kaneka Medical America LLC | $2,367 |
| Sanofi-aventis U.S. LLC | $2,000 |
| AstraZeneca | $2,000 |